ERBB2 and cancer: Black and Hispanic women younger than 35 years have been found to have a poorer survival than White women [23], a finding that could be due, in part, to the lower proportion of HR+/HER2- cancer in Black and Hispanic AYAs and a higher proportion of triple-negative breast cancer in Blacks.